TLR9 and infection: Our approach was different because we administered TLR-9 agonists (CpG-ODN) before infection, in an attempt to prevent hemorrhage-induced MSSA PN, and CpG-ODN treatment decreased the mortality as well as restoring the transcriptional activity of DCs.